Welcome

 

The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft which is combining a team of transdisciplinary scientists, academic and industrial partners from several countries. It follows a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of non-invasive diagnostic methods combining molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.

If you like to support our research, donations are very welcome. For bank details, please send a short request to office@lbiad.lbg.ac.at.

Thank you very much!

Recent News

LBG Meeting for Health Sciences 2018


The LBG Meeting for Health Sciences 2018 took place in Vienna on the 29th and 30th of November. The focus was on the translation of research results from theory into practice.
Therefore,
Press conference "Movember"


To raise awareness for men’s health issues, the Ludwig Boltzmann Institute Applied Diagnostics hold together with representatives of the Medical University of Vienna a press conference at
Der LBG Weinherbst 2018


"Wir waren auf der Suche nach Druckpunkten bei der Diagnose, Behandlung und Rehabilitation von Unfallverletzungen. Diese haben wir bei einer Crowdsourcing-Kampagne, die über den Sommer gelaufen
New project funded


Together, Thomas L. Mindt and his cooperation-partners Wolfgang Kandioller (University of Vienna) and Berthold Nock (Demokritos, Athens) received a grant by the Austrian Science Fund for the new
New Podcast - Epigenetic Biomarkers in Cancer


This podcast with Professor Gerda Egger (Department of Pathology, Medical University of Vienna and Ludwig Boltzmann Institute Applied Diagnostics) provides an overview

Share This: